This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Dr. Jing Zhu, PhD
VP, Head of Process and Analytical Development at ReciBioPharm
Speaker

Profile

Jing Zhu is the Vice President, Head of Process and Analytical Development, at ReciBioPharm, overseeing ATMP process development activities and technology platform establishment. He has 15+ years of experience in process and analytical development, chemistry manufacturing controls (CMC) program steering within the pharmaceutical industry. Prior to joining ReciBioParm, Jing has been at various leadership roles crossing biotech pharma and vendor companies in nuclei acid and viral vector fields.

Agenda Sessions

  • CMC Best Practices and Lessons Learned in Manufacturing from Sequence to IND for a Gene Editing Program

    8:30am